JPH203, a newly developed anti-cancer drug, shows a preincubation inhibitory effect on L-type amino acid transporter 1 function
Kentaro Okunushi(Chiba University), Naohiko Anzai(Dokkyo Medical University), Shinichi Sakamoto(Chiba University), Tomomi Furihata(Chiba University), Meika Kaneko(Chiba University), Naoki Shimojo, Yuta Ohno(Chiba University), Yoshie Reien(Chiba University), Yasuhiro Watanabe(National Defense Medical College), Kosuke Higuchi(Chiba University), Hanae Morio(Chiba University), Yusuke Otsuka(Chiba University), Yasuhide Muto(Social Welfare Organization Saiseikai Imperial Gift Foundation), Kiyoshi Nakagawa(Chiba University), Hidefumi Wakashin(Dokkyo Medical University)
Cited by 40
Related Papers
Enhanced early skin treatment for atopic dermatitis in infants reduces food allergy
|Journal of Allergy and Clinical Immunology|2023|84
Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203
|Anticancer Research|2018|39
Adrenaline increases glucose transport via a Rap1‐p38MAPK pathway in rat vascular smooth muscle cells
|British Journal of Pharmacology|2007|26
Comparison of Efficacy of Self-Expandable Metallic Stent Placement in the Unresectable Esophageal Cancer Patients
|Gastroenterology Research and Practice|2017|19
Endoscopic occlusion with silicone spigots for the closure of refractory esophago-bronchiole fistula after esophagectomy
|World Journal of Gastroenterology|2017|7